Free CE/CMEVideo

Project ECHO®: From Recurrence Risk to Treatment Choice: Leveraging Genomic and Clinical Data in Early HR+/HER2– Breast Cancer

Release Date

November 16, 2026

Expiration Date

November 17, 2027

Credits

1.0 CME, NCPD

Activity Overview

This online, on-demand virtual symposium brings together renowned experts in hormone receptor–positive/HER2-negative (HR+/HER2–) breast cancer. In this educational program, these experts use case-based discussions to explore real-world scenarios across the HR+/HER2– breast cancer continuum—from genomic risk stratification and adjuvant therapy selection in early-stage disease to the selection and sequencing of targeted therapies in advanced/metastatic disease.

This educational activity is an archive of the live symposium held on November 2, 2026.

Target Audience

This educational activity is directed toward medical oncologists, surgical oncologists, radiation oncologists, advanced practice providers, nurses, and other health care providers involved in the treatment and management of HR+/HER2– breast cancer.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Describe key distinctions between available genomic risk assays to determine appropriate indications for use
  • Apply evidence-based approaches to risk stratification in early-stage HR+/HER2– breast cancer to guide individualized adjuvant therapy decisions
Project ECHO®: From Recurrence Risk to Treatment Choice: Leveraging Genomic and Clinical Data in Early HR+/HER2– Breast Cancer

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from AstraZeneca Pharmaceuticals.

Follow Us on Social Media!

You Also Might Like...

Course

Project ECHO®: From Recurrence Risk to Treatment Choice: Leveraging Genomic and Clinical Data in Early HR+/HER2– Breast Cancer

Create Account